Old Web
English
Sign In
Acemap
>
Paper
>
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.
2021
Philipp Sievers
Damian Stichel
Martin Sill
Daniel Schrimpf
Dominik Sturm
Florian Selt
Jonas Ecker
Daniel Kazdal
Evelina Miele
Mariëtte E.G. Kranendonk
Bastiaan B. J. Tops
Patricia Kohlhof-Meinecke
Rudi Beschorner
Christof M. Kramm
Martin Hasselblatt
Guido Reifenberger
David Capper
Pieter Wesseling
Albrecht Stenzinger
Till Milde
Andrey Korshunov
Olaf Witt
Stefan M. Pfister
Wolfgang Wick
Andreas von Deimling
David T. W. Jones
Felix Sahm
Keywords:
drug target
Glioma
Cancer research
ROS1
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
12
References
0
Citations
NaN
KQI
[]